Skip to content
Riskpilot
← Back to search
Sign in
Get full access
AdaptVac ApS
APS
Active
Advertising protection
CVR 38732730
Nordre Fasanvej 215, 2000
Frederiksberg
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2017 · 8 years old
9 employees
www.adaptvac.com
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
AdaptVac ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
WA
Willem Adriaan De Jongh
Chief Executive Officer
Chief Executive Officer
2017
AF
Adam Frederik Sander Bertelsen
Management
Management
2017
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
AE
Ali El-Salanti
Board of Directors
Board of Directors
2017
JH
Jacob Hjulmand
Board of Directors
Board of Directors
2021
AR
Allan Rosetzsky
Board of Directors
Board of Directors
2020
MA
Morten Agertoug Nielsen
Chairman
Chairman
2020
Former (2)
SS
Steen Søren Klysner
Chairman
Chairman
2017 – 2020
BU
Bent Ulrich Frandsen
Board of Directors
Board of Directors
2017 – 2021
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
NextGen Vaccines Holding ApS
Company
50–66.65%
50–66.65%
2017
EXPRES2ION BIOTECHNOLOGIES ApS
Company
33.33–49.99%
33.33–49.99%
2021
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on AdaptVac ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network